Evidence map›Paper›PMID 27496553›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Ararat Chakhoyan, Aurélien Corroyer-Dulmont, Marine M Leblond, Aurélie Gérault, Jérôme Toutain, Laurent Chazaviel, Didier Divoux, Edwige Petit, Eric T MacKenzie, François Kauffmann and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Gas Delivery Relevant to Human Health using Porous Materials.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  5. Article
  6. Hemodynamic and metabolic changes during hypercapnia with normoxia and hyperoxia using pCASL and TRUST MRI in healthy adults.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Ararat Chakhoyan1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Aurélien Corroyer-Dulmont1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Marine M Leblond1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Aurélie Gérault1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Jérôme Toutain1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Laurent Chazaviel1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Didier Divoux1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Edwige Petit1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Eric T MacKenzie1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
François Kauffmann4 Normandie Univ, Esplanade de la Paix, Caen, France.
Nicolas Delcroix3 UNICAEN, GIP CYCERON, Caen, France.
Myriam Bernaudin1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Omar Touzani1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Samuel Valable1 CNRS, UMR6301-ISTCT, CERVOxy Group, GIP CYCERON, Caen, France.
Cyceron · FRNormandie Université · FRUniversité de Caen Normandie · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The alleviation of hypoxia in glioblastoma with carbogen to improve treatment has met with limited success. Our hypothesis is that the eventual benefits of carbogen depend on the capacity for vasodilation. We examined, with MRI, changes in fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent signals in response to carbogen. The analyses were performed in two xenograft models of glioma (U87 and U251) recognized to have different vascular patterns. Carbogen increased fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent signals in contralateral tissues. In the tumor core and peritumoral regions, changes were dependent on the capacity to vasodilate rather than on resting fractional cerebral blood volume. In the highly vascularised U87 tumor, carbogen induced a greater increase in fractional cerebral blood volume and blood oxygen saturation in comparison to the less vascularized U251 tumor. The blood oxygenation level dependent signal revealed a delayed response in U251 tumors relative to the contralateral tissue. Additionally, we highlight the considerable heterogeneity of fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent within U251 tumor in which multiple compartments co-exist (tumor core, rim and peritumoral regions). Finally, our study underlines the complexity of the flow/metabolism interactions in different models of glioblastoma. These irregularities should be taken into account in order to palliate intratumoral hypoxia in clinical trials.

Indexed as

AnimalsBrain NeoplasmsCarbon DioxideCerebrovascular CirculationGlioblastomaHumansMagnetic Resonance ImagingOxygenRats, NudeXenograft Model Antitumor AssayscarbogenCarbon DioxideOxygenDynamic blood oxygenation level dependentfractional cerebral blood volumegliomahypoxiatissue oxygen saturation

Identifiers

PMID27496553
PMCPMC5464716
OpenAlexW2502674585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.